Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 18, 2005

View Archived Issues

Antithrombotic efficacy of dual-acting MC-45308

Oxytocin receptor antagonists in the prevention of preterm labor

Renal impairment does not significantly affect the PK profile of oral naftidrofuryl

Anticoagulant and antiinflammatory effects of rhAT in healthy volunteers

Darifenacin improves quality of life of patients with overactive bladder

Recent patents cover novel treatments for cognitive disorders

Novel antiglaucoma agents jointly disclosed by Ube and Santen

Vanilloid VR1 receptor modulators emerge from recent R&D

Antiviral efficacy and pharmacokinetics of single-oral dose PA-457 reported in HIV-infected patients

Antiviral efficacy and pharmacokinetics of vicriviroc alone or in combination with other antivirals

Thiovir effective against resistant HIV-1 strains and synergistic with zidovudine

ImClone Systems and UCB enter partnership for CDP-791

Vicuron stockholders vote to approve acquisition by Pfizer

Dosing begins in phase I study of GS-9132 for HCV

Vaqta approved for children as young as 12 months of age

Pfizer completes acquisition of Bioren

Astellas reports discovery of novel reverse NCX inhibitor YM-270951

Predix begins pivotal study with PRX-00023 for generalized anxiety disorder

Akorn signs agreement for AK-1015

Alnylam awarded grant for Parkinson's research

Positive phase III results for Desilux

Migenix cleared to begin phase IIb study of MX-3253 in Canada

HuMax-CD20 enters phase II study for rheumatoid arthritis

Schering-Plough exercises rights to CNTO-148

Japanese approval for Amplatzer Septal Occluder for atrial septal occlusion

Promising preliminary results for HER-2 Protein AutoVac in breast cancer

Otsuka to launch Meptin Clickhaler in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...